Table S5 from Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Associations between molecular features and clinical outcome. Patient outcome and changes in pSTAT3+, SMA+, Ki67+ cells and distance between Ki67+&SMA+ cells are indicated. Initial values from Day 0 where possible, otherwise Day 1. For continuous data, increase or decrease of at least 5% of initial value used as a threshold. Changes computed as Time0 - mean (Time 2,4,6 weeks). Outcome is percentage shrinkage of tumor at week 6.